861
|
|
|
AT-rich interaction domain 1B |
6A3-5, BAF250B, BRIGHT, CSS1, DAN15, ELD/OSA1, MRD12, OSA2, P250R, SMARCF2 |
Alzheimer disease, Asthma, Attention deficit hyperactivity disorder, Autism, Breast cancer, Hepatocellular carcinoma, Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, Coffin-siris syndrome, Color vision deficiency, Desbuquois syndrome, Developmental disability, Epilepsy, Global developmental delay, Hypertrichosis, Intellectual developmental disorder, Neuroblastoma, Neurodevelopmental disorder, Pituitary stalk interruption syndrome, Psychiatric disorders, Schizophrenia, Severe combined immunodeficiency, Substance abuse, Diabetes mellitus type 2, Wiedemann-steiner syndromeView all (9 more) |
862
|
|
|
AT-rich interaction domain 2 |
BAF200, CSS6, SMARCF3, ZIPZAP, p200 |
|
863
|
|
|
AT-rich interaction domain 3A |
BRIGHT, DRIL1, DRIL3, E2FBP1 |
|
864
|
|
|
AT-rich interaction domain 3B |
BDP, DRIL2 |
|
865
|
|
|
AT-rich interaction domain 3C |
- |
|
866
|
|
|
AT-rich interaction domain 4A |
RBBP-1, RBBP1, RBP-1, RBP1 |
|
867
|
|
|
AT-rich interaction domain 4B |
BCAA, BRCAA1, RBBP1L1, RBP1L1, SAP180 |
|
868
|
|
|
AT-rich interaction domain 5A |
MRF-1, MRF1, RP11-363D14 |
|
869
|
|
|
AT-rich interaction domain 5B |
DESRT, MRF-2, MRF2 |
Rheumatoid arthritis, Attention deficit hyperactivity disorder, Autoimmune disease, Autoimmune thyroid disease, B-cell acute lymphoblastic leukemia, Cannabis abuse, Adenoid cystic carcinoma, Basal cell carcinoma, Cardiovascular disease, Lymphoblastic leukemia, Cleft palate, Congenital retrognathism, Global developmental delay, Gout, Graves disease, Hearing loss, Heart failure, Hypothyroidism, Keratoconus, Schizophrenia, Squamous cell carcinoma, Substance abuse, Systemic lupus erythematosus, Thyroid disease, Diabetes mellitus type 2, VitiligoView all (11 more) |
870
|
|
|
Ariadne RBR E3 ubiquitin protein ligase 1 |
ARI, HARI, HHARI, UBCH7BP |
|